Terms: = Skin cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181
9 results:
1. The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Feichtenschlager V; Chen L; Zheng YJ; Ho W; Sanlorenzo M; Vujic I; Fewings E; Lee A; Chen C; Callanan C; Lin K; Qu T; Hohlova D; Vujic M; Hwang Y; Lai K; Chen S; Nguyen T; Muñoz DP; Kohwi Y; Posch C; Daud A; Rappersberger K; Kohwi-Shigematsu T; Coppé JP; Ortiz-Urda S
Mol Cancer; 2024 Feb; 23(1):40. PubMed ID: 38383439
[TBL] [Abstract] [Full Text] [Related]
2. cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
Wickström SL; Lövgren T; Volkmar M; Reinhold B; Duke-Cohan JS; Hartmann L; Rebmann J; Mueller A; Melief J; Maas R; Ligtenberg M; Hansson J; Offringa R; Seliger B; Poschke I; Reinherz EL; Kiessling R
Front Immunol; 2019; 10():2766. PubMed ID: 31921104
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho.
Behera R; Kaur A; Webster MR; Kim S; Ndoye A; Kugel CH; Alicea GM; Wang J; Ghosh K; Cheng P; Lisanti S; Marchbank K; Dang V; Levesque M; Dummer R; Xu X; Herlyn M; Aplin AE; Roesch A; Caino C; Altieri DC; Weeraratna AT
Clin Cancer Res; 2017 Jun; 23(12):3181-3190. PubMed ID: 28232477
[No Abstract] [Full Text] [Related]
4. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract] [Full Text] [Related]
5. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
Shah AA; Bourne TD; Murali R
Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622
[TBL] [Abstract] [Full Text] [Related]
6. Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.
Freedman GM; Anderson PR; Bleicher RJ; Litwin S; Li T; Swaby RF; Ma CM; Li J; Sigurdson ER; Watkins-Bruner D; Morrow M; Goldstein LJ
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):888-93. PubMed ID: 22580118
[TBL] [Abstract] [Full Text] [Related]
7. Identification of melanoma antigens using a Serological Proteome Approach (SERPA).
Suzuki A; Iizuka A; Komiyama M; Takikawa M; Kume A; Tai S; Ohshita C; Kurusu A; Nakamura Y; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Akiyama Y
Cancer Genomics Proteomics; 2010; 7(1):17-23. PubMed ID: 20181627
[TBL] [Abstract] [Full Text] [Related]
8. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
[TBL] [Abstract] [Full Text] [Related]
9. Stereotactic 11-gauge vacuum-assisted breast biopsy: influence of number of specimens on diagnostic accuracy.
Lomoschitz FM; Helbich TH; Rudas M; Pfarl G; Linnau KF; Stadler A; Jackman RJ
Radiology; 2004 Sep; 232(3):897-903. PubMed ID: 15273332
[TBL] [Abstract] [Full Text] [Related]